Pregnancy Seems to Ease MS Symptoms, and Research May Show Why
THURSDAY, June 15, 2023 (HealthDay News) — Women with multiple sclerosis temporarily get much better when pregnant, and researchers now think they know why.Pregnancy causes a downshift in a woman’s immune system, and it appears that this unintentiona…
Learn MorePregnancy Seems to Ease MS Symptoms, and Research May Show Why
THURSDAY, June 15, 2023 (HealthDay News) — Women with multiple sclerosis temporarily get much better when pregnant, and researchers now think they know why.Pregnancy causes a downshift in a woman’s immune system, and it appears that this unintentiona…
Learn MoreCrohn’s Disease: What Is It, and How Can It Be Treated?
THURSDAY, June 15, 2023 (HealthDay News) — Crohn’s disease can turn your life into a gastrointestinal nightmare, but there is hope.According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), more than half a million Ame…
Learn MoreCrohn’s Disease: What Is It, and How Can It Be Treated?
THURSDAY, June 15, 2023 (HealthDay News) — Crohn’s disease can turn your life into a gastrointestinal nightmare, but there is hope.According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), more than half a million Ame…
Learn MoreObesity Linked to Increased Risk for Mental Health Diagnoses
WEDNESDAY, June 14, 2023 (HealthDay News) — Obesity is associated with an increased risk for mental health diagnoses, according to a study published online May 30 in Translational Psychiatry.Michael Leutner, Ph.D., from the Medical University of Vien…
Learn MoreFDA Approves Linzess to Treat Constipation in Children, Teens
WEDNESDAY, June 14, 2023 (HealthDay News) — The U.S. Food and Drug Administration approved Linzess (linaclotide) as a once-daily treatment for pediatric patients ages 6 to 17 years with functional constipation. The approval was based on data from 328…
Learn MoreFDA Advisers Meet to Decide Next COVID-19 Booster Shot
WEDNESDAY, June 14, 2023 (HealthDay News) — COVID-19 boosters may be offered this fall, but first scientists need to determine what strains to target and who should receive the shots.Advisers to the U.S. Food and Drug Administration are slated to mee…
Learn MoreCrohn Disease More Common in People With Hidradenitis Suppurativa
WEDNESDAY, June 14, 2023 (HealthDay News) — Pediatric patients with hidradenitis suppurativa (HS) have a higher prevalence of Crohn disease, according to a research letter published online June 14 in JAMA Dermatology.Nicole Mastacouris, from the Dona…
Learn MoreEarly Intervention for Psoriasis With Guselkumab Tied to Complete Response
WEDNESDAY, June 14, 2023 (HealthDay News) — Guselkumab is consistently effective across subpopulations for the treatment of moderate-to-severe plaque psoriasis, according to a study published June 1 in the Journal of the European Academy of Dermatolo…
Learn MoreLa FDA aprueba la venta sin receta de un gel tópico para la disfunción eréctil
MARTES, 13 de junio de 2023 (HealthDay News) — Ahora, los hombres con disfunción eréctil tendrán la opción de usar un gel tópico para tratar la afección. La Administración de Alimentos y Medicamentos (FDA) de EE. UU. aprobó el mercadeo sin receta del…
Learn More